Arboclofen Has Potential to Improve Social Function and Behavior in Patients with Fragile X Syndrome

Source: 
Science Translational Medicine
Date Published: 
September 9, 2012
Abstract: 

Research on animal models suggests that STX209 (arboclofen) might improve neurobehavioral function in patients affected with Fragile X Syndrome.